Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.375 AUD | -1.32% | -1.32% | +44.23% |
Apr. 18 | SciDev Posts AU$29 Million Revenue in Fiscal Q3 | MT |
Apr. 10 | SciDev Wins AU$2 Million Water Treatment Contract | MT |
Valuation
Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 9.225 | 81.72 | 134.6 | 33.81 | 62.65 | 71.19 | - | - |
Enterprise Value (EV) 1 | 9.225 | 81.72 | 127.9 | 19.75 | 54.92 | 66.49 | 63.19 | 58.59 |
P/E ratio | - | - | 38.1 x | - | -183 x | 20.8 x | 12.1 x | 9.62 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 3.16 x | 4.52 x | 3.17 x | 0.61 x | 0.7 x | 0.67 x | 0.61 x | 0.57 x |
EV / Revenue | 3.16 x | 4.52 x | 3.01 x | 0.36 x | 0.61 x | 0.62 x | 0.54 x | 0.47 x |
EV / EBITDA | -5.24 x | -43.8 x | 61.2 x | 9.41 x | 13.5 x | 6.86 x | 4.79 x | 3.71 x |
EV / FCF | - | - | -32.9 x | -2.48 x | -15.3 x | -111 x | 11.1 x | 8.37 x |
FCF Yield | - | - | -3.04% | -40.3% | -6.52% | -0.9% | 9.02% | 11.9% |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 107,263 | 140,889 | 158,370 | 187,857 | 189,853 | 189,853 | - | - |
Reference price 2 | 0.0860 | 0.5800 | 0.8500 | 0.1800 | 0.3300 | 0.3750 | 0.3750 | 0.3750 |
Announcement Date | 8/30/19 | 8/26/20 | 8/31/21 | 8/31/22 | 8/28/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 2.921 | 18.06 | 42.52 | 55.6 | 89.84 | 107 | 116 | 125.3 |
EBITDA 1 | -1.761 | -1.866 | 2.088 | 2.098 | 4.08 | 9.7 | 13.2 | 15.8 |
EBIT 1 | - | -2.243 | 1.159 | 0.016 | 0.572 | 5.6 | 9 | 11.3 |
Operating Margin | - | -12.42% | 2.72% | 0.03% | 0.64% | 5.23% | 7.76% | 9.02% |
Earnings before Tax (EBT) 1 | - | - | 0.8057 | - | -0.222 | 5 | 8.4 | 10.7 |
Net income 1 | - | - | 3.453 | -0.616 | -0.339 | 3.5 | 5.8 | 7.5 |
Net margin | - | - | 8.12% | -1.11% | -0.38% | 3.27% | 5% | 5.99% |
EPS 2 | - | - | 0.0223 | - | -0.001800 | 0.0180 | 0.0310 | 0.0390 |
Free Cash Flow 1 | - | - | -3.885 | -7.956 | -3.58 | -0.6 | 5.7 | 7 |
FCF margin | - | - | -9.14% | -14.31% | -3.98% | -0.56% | 4.91% | 5.59% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | 43.18% | 44.3% |
FCF Conversion (Net income) | - | - | - | - | - | - | 98.28% | 93.33% |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 8/30/19 | 8/26/20 | 8/31/21 | 8/31/22 | 8/28/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: June | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S2 |
---|---|---|---|---|---|
Net sales 1 | 18.33 | 24.19 | 24.14 | 31.46 | 40.31 |
EBITDA 1 | 0.9388 | 1.15 | -0.423 | - | 1.585 |
EBIT | - | - | - | - | - |
Operating Margin | - | - | - | - | - |
Earnings before Tax (EBT) | - | - | - | - | - |
Net income | - | - | - | - | - |
Net margin | - | - | - | - | - |
EPS 2 | - | 0.0195 | - | - | -0.001900 |
Dividend per Share 2 | - | - | - | - | - |
Announcement Date | 2/7/21 | 8/31/21 | 2/21/22 | 8/31/22 | 8/28/23 |
Balance Sheet Analysis
Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - | - |
Net Cash position 1 | - | - | 6.73 | 14.1 | 7.73 | 4.7 | 8 | 12.6 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | -3.88 | -7.96 | -3.58 | -0.6 | 5.7 | 7 |
ROE (net income / shareholders' equity) | - | - | 14.1% | -1.53% | -0.7% | 6.9% | 10.8% | 12.6% |
ROA (Net income/ Total Assets) | - | - | 8.29% | -0.97% | -0.49% | 8.5% | 13.4% | 16.5% |
Assets 1 | - | - | 41.66 | 63.66 | 69.27 | 41.18 | 43.28 | 45.45 |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share 2 | - | - | -0.0100 | -0.0100 | 0.0300 | 0.0400 | 0.0500 | 0.0600 |
Capex 1 | - | - | 0.41 | 2.38 | 4.11 | 3.7 | 4.3 | 4.9 |
Capex / Sales | - | - | 0.97% | 4.28% | 4.58% | 3.46% | 3.71% | 3.91% |
Announcement Date | 8/30/19 | 8/26/20 | 8/31/21 | 8/31/22 | 8/28/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+44.23% | 46.43M | |
+9.52% | 42.18B | |
-4.13% | 12.05B | |
+5.38% | 5.23B | |
-6.56% | 4.3B | |
-1.12% | 3.87B | |
-1.76% | 2.41B | |
+6.17% | 2.07B | |
-7.29% | 1.51B | |
+2.34% | 1.42B |
- Stock Market
- Equities
- SDV Stock
- Financials SciDev Limited